Linda Coleman
Internal Medicine · Sterling, VANPI 1457344095
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $625 and has fallen 84.3% since, to $98 in 2025.
Across 127 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$417
- Novo Nordisk$352
- Lilly USA, LLC$194
- Takeda Pharmaceuticals U.S.A., Inc.$172
- AstraZeneca$127
- Galderma Laboratories, L.p.$87
- plus $834 from 28 others
What the payments were for
- Food & beverage$2,17199%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $417 |
| Novo Nordisk | 22 | $352 |
| Lilly USA, LLC | 11 | $194 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $172 |
| AstraZeneca | 7 | $127 |
| Galderma Laboratories, L.p. | 6 | $87 |
| Abbott | 4 | $83 |
| Boehringer Ingelheim | 3 | $70 |
| Pfizer | 3 | $63 |
| Merck | 4 | $53 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Amarin Pharma, Inc. | 2 | $38 |
| Genentech USA, Inc. | 2 | $37 |
| Johnson & Johnson | 2 | $36 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Currax Pharmaceuticals LLC | 2 | $28 |
| GSK | 1 | $25 |
| PBG Puerto Rico LLC | 1 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $25 |
| Medtronic | 1 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Exact Sciences | 1 | $23 |
| Eisai Inc. | 1 | $23 |
| Acella Pharmaceuticals, LLC | 1 | $20 |
| Antares Pharma, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Merz North America, Inc. | 1 | $16 |
| Seqirus USA Inc | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Clarus Therapeutics Inc. | 1 | $12 |
How this compares
$2,183 in reported general payments places this provider in the 85th percentile of 2,724 internal medicine providers in Virginia.
Other internal medicine in Sterling
- Kumar AbhishekMechanicsville$1M
- Amit MahajanFalls Church$1M
- Kevin DonohueFalls Church$655K
- Denise BrunerArlington$227K
- Anjali KaloreMidlothian$215K
- Scott GerrishVienna$207K
- Lawrence SchwartzRichmond$205K
- Wally SmithRichmond$177K
- Gautam GulatiMc Lean$136K
- Francesse BatailleDumfries$109K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.